CLEARPOINT NEURO INC.

ClearPoint Neuro to Present at the UBS Global Healthcare Virtual Conference

19 May 2021 15:05:00 By Nasdaq GlobeNewswire

ClearPoint Neuro, Inc. Announces First-in-Human Cases of the SmartFrame Array™ Neuro Navigation System and Software

18 May 2021 15:05:00 By Nasdaq GlobeNewswire

ClearPoint Neuro Reports Record Revenue in First Quarter 2021 Results, Announces FDA Clearance of the SmartFrame ‘Array’

11 May 2021 15:05:01 By Nasdaq GlobeNewswire

ClearPoint Neuro Announces Partnership With D&K Engineering for Development of Robotic System for the MRI Suite and Operating Room

10 May 2021 16:21:03 By Nasdaq GlobeNewswire

ClearPoint Neuro to Announce First Quarter 2021 Results May 11, 2021

29 Apr 2021 15:38:06 By Nasdaq GlobeNewswire

ClearPoint Neuro Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

23 Apr 2021 16:00:00 By Nasdaq GlobeNewswire

ClearPoint Neuro, Inc. Announces Retirement of Director John N. Spencer, Jr.

13 Apr 2021 15:05:00 By Nasdaq GlobeNewswire

ClearPoint Neuro, Inc. Congratulates uniQure on Completion of Enrollment in First Cohort of Phase I/II Clinical Trial of AMT-130 for the Treatment of Huntington’s Disease

06 Apr 2021 15:05:00 By Nasdaq GlobeNewswire

ClearPoint Neuro, Inc. Announces Appointment of Ellisa Cholapranee as General Counsel

24 Mar 2021 15:05:00 By Nasdaq GlobeNewswire

ClearPoint Neuro Reports Fourth Quarter and Full-Year 2020 Results

04 Mar 2021 15:05:01 By Nasdaq GlobeNewswire

ClearPoint Neuro Announces Closing of Public Offering of 2,127,660 Shares of Common Stock

23 Feb 2021 15:05:00 By Nasdaq GlobeNewswire

ClearPoint Neuro to Announce Fourth Quarter and Full Year 2020 Results on March 4, 2021

19 Feb 2021 15:05:00 By Nasdaq GlobeNewswire

ClearPoint Neuro Announces Pricing of Public Offering of 1,850,140 Shares of Common Stock

18 Feb 2021 21:10:42 By Nasdaq GlobeNewswire

ClearPoint Neuro Launches Proposed Public Offering of Common Stock

18 Feb 2021 15:35:38 By Nasdaq GlobeNewswire

ClearPoint Neuro, Inc. Announces License and Research Agreement with Philips

18 Feb 2021 15:05:00 By Nasdaq GlobeNewswire

ClearPoint Neuro, Inc. Announces Multi-Product Joint Development & Option Agreement with Blackrock Microsystems

11 Feb 2021 15:05:00 By Nasdaq GlobeNewswire

ClearPoint Neuro, Inc. Announces Appointment of R. John Fletcher as Chairman of the Board of Directors

05 Feb 2021 07:00:00 By Nasdaq GlobeNewswire

ClearPoint Neuro, Inc. Announces Expansion of Pre-Clinical and Translational Development Team to Support Gene and Stem Cell Therapy Partners

26 Jan 2021 15:05:00 By Nasdaq GlobeNewswire

ClearPoint Neuro, Inc. Announces First Procedure Utilizing ClearPoint® 2.0 Software in Europe

14 Jan 2021 15:05:00 By Nasdaq GlobeNewswire

ClearPoint Neuro, Inc. Reports Record Revenue in Preliminary Fourth Quarter 2020 Results

12 Jan 2021 15:05:00 By Nasdaq GlobeNewswire